These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Hope, humanity, and Huntington's disease in Latin America. Burton A Lancet Neurol; 2013 Feb; 12(2):133-4. PubMed ID: 23332359 [No Abstract] [Full Text] [Related]
63. Hunting biomarkers for Huntington's disease: H2AFY. Lake F Biomark Med; 2011 Dec; 5(6):817-20. PubMed ID: 22103616 [No Abstract] [Full Text] [Related]
64. Key role of nuclear medicine in seeking biomarkers of Huntington's disease. Squitieri F; Ciarmiello A Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1124-7. PubMed ID: 20358195 [No Abstract] [Full Text] [Related]
65. Huntington's Disease With Psychotic Features. Yeo K; Gupta M; Correll CU Prim Care Companion CNS Disord; 2021 Aug; 23(4):. PubMed ID: 34352939 [No Abstract] [Full Text] [Related]
66. A clinical method of estimating risk of drug induced delirium. Summers WK Life Sci; 1978 May; 22(17):1511-6. PubMed ID: 672410 [No Abstract] [Full Text] [Related]
67. [Delirium and dementia]. Dieterich M Fortschr Neurol Psychiatr; 2014 Sep; 82(9):491. PubMed ID: 25177900 [No Abstract] [Full Text] [Related]
68. The management of dementia: a review of some possibilities. Miller E Br J Soc Clin Psychol; 1977 Feb; 16(1):77-83. PubMed ID: 321065 [TBL] [Abstract][Full Text] [Related]
69. Delirium induced by a new synthetic legal intoxicating drug: phenazepam. Ali A; Jerry JM; Khawam EA Psychosomatics; 2015; 56(4):414-8. PubMed ID: 25555294 [No Abstract] [Full Text] [Related]
70. Huntington disease: clinical care and evaluation. Shoulson I; Fahn S Neurology; 1979 Jan; 29(1):1-3. PubMed ID: 154626 [No Abstract] [Full Text] [Related]
71. The ever expanding issue of later life mental health. Glynn K; Lyne J Ir J Psychol Med; 2019 Jun; 36(2):83-84. PubMed ID: 31187726 [No Abstract] [Full Text] [Related]
72. Psychological Interventions for People with Huntington's Disease: A Call to Arms. Zarotti N; Dale M; Eccles F; Simpson J J Huntingtons Dis; 2020; 9(3):231-243. PubMed ID: 32894248 [TBL] [Abstract][Full Text] [Related]
74. International Guidelines for the Treatment of Huntington's Disease. Bachoud-Lévi AC; Ferreira J; Massart R; Youssov K; Rosser A; Busse M; Craufurd D; Reilmann R; De Michele G; Rae D; Squitieri F; Seppi K; Perrine C; Scherer-Gagou C; Audrey O; Verny C; Burgunder JM Front Neurol; 2019; 10():710. PubMed ID: 31333565 [TBL] [Abstract][Full Text] [Related]
75. Nucleic Acid-Based Therapy Approaches for Huntington's Disease. Vagner T; Young D; Mouravlev A Neurol Res Int; 2012; 2012():358370. PubMed ID: 22288011 [TBL] [Abstract][Full Text] [Related]
76. Treatment of Irritability in Huntington's Disease. van Duijn E Curr Treat Options Neurol; 2010 Sep; 12(5):424-33. PubMed ID: 20730109 [TBL] [Abstract][Full Text] [Related]
77. Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body. Martin B; Golden E; Keselman A; Stone M; Mattson MP; Egan JM; Maudsley S Histol Histopathol; 2008 Feb; 23(2):237-50. PubMed ID: 17999380 [TBL] [Abstract][Full Text] [Related]
78. Successful multimodality treatment of severe behavioral disturbance in a patient with advanced Huntington's disease. Blass DM; Steinberg M; Leroi I; Lyketsos CG Am J Psychiatry; 2001 Dec; 158(12):1966-72. PubMed ID: 11729010 [No Abstract] [Full Text] [Related]
79. Use of applied behavior analysis in treating nursing home residents. Lundervold DA; Jackson T Hosp Community Psychiatry; 1992 Feb; 43(2):171-3. PubMed ID: 1533384 [No Abstract] [Full Text] [Related]
80. Combination psychopharmacological and behavioral therapy in Huntington's chorea: a case study. Freinhar JP; Alvarez WA; Chambers ML Int J Psychosom; 1985; 32(2):17-9. PubMed ID: 3160678 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]